如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Pentosidine (1 mg vial)
產(chǎn)品型號(hào): SAE-3242-v
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Pentosidine (1 mg vial)
Pentosidine (1 mg vial)
的詳細(xì)介紹
- Trifluoroacetate Salt
- Product Code: SAE-3242-v
- Synonyms/Product Alternate Names: (S)-2-Amino-6-(2-(((S)-4-Amino-4-Carboxybutyl)Amino)-4H-Imidazo[4,5-b]Pyridin-4-yl)Hexanoic Acid
- Advanced Glycation End Product (AGE) / Biomarker for Glycation-Oxidative Stress (e.g. in Diabetes)
- Storage Conditions: -20 °C
- Purity: ≧98.0% (HPLC)
- Molecular Weight: 378.43
- Molecular Formula: C17H26N6O4
- CAS Number: 124505-87-9
D.R. Sell, and V.M. Monnier, J. Biol. Chem., 264, 21597 (1989). (Original)
T. Miyata, Y. Ueda, K. Horie, M. Nangaku, S. Tanaka, C.Y. Strihou, and K. Kurokawa, Kidney Int., 53, 416 (1998). (Pharmacol.)
D. Slowik-?ylka, K. Safranow, V. Dziedziejko, H. Bukowska, K. Ciechanowski, and D. Chlubek, J. Biochem. Biophys. Methods, 61, 313 (2004). (Specific Determination of Pentosidine in Plasma)
M. Saito, and K. Marumo, Osteoporos. Int., 21, 195 (2010). (Clinical Review; Estimation of Fracture Risk)
R. Furuya, H. Kumagai, T. Miyata, H. Fukasawa, S. Isobe, N. Kinoshita, and A. Hishida, Clin. Exp. Nephrol., 16, 421 (2012). (Clinical; Correlation to Cardiovascular Risk)
M. Yamamoto, and T. Sugimoto, Curr. Osteoporos. Rep., 14, 320 (2016). (Review)
